You are here

Zogenix to Present at the 8th Annual SVB Leerink Global Healthcare Conference

EMERYVILLE, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that Stephen J. Farr, President and CEO, will provide a corporate update at the 8th Annual SVB Leerink Global Healthcare Conference, being held February 27-March 1, 2019, in New York, NY.
Wednesday, February 20, 2019 - 08:00